Correlation Between Pasithea Therapeutics and Dyadic International
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Dyadic International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Dyadic International into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Dyadic International, you can compare the effects of market volatilities on Pasithea Therapeutics and Dyadic International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Dyadic International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Dyadic International.
Diversification Opportunities for Pasithea Therapeutics and Dyadic International
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pasithea and Dyadic is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Dyadic International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyadic International and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Dyadic International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyadic International has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Dyadic International go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Dyadic International
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to under-perform the Dyadic International. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 1.4 times less risky than Dyadic International. The stock trades about -0.04 of its potential returns per unit of risk. The Dyadic International is currently generating about 0.41 of returns per unit of risk over similar time horizon. If you would invest 105.00 in Dyadic International on August 31, 2024 and sell it today you would earn a total of 82.00 from holding Dyadic International or generate 78.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 50.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Dyadic International
Performance |
| Timeline |
| Pasithea Therapeutics |
| Dyadic International |
Pasithea Therapeutics and Dyadic International Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Dyadic International
The main advantage of trading using opposite Pasithea Therapeutics and Dyadic International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Dyadic International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyadic International will offset losses from the drop in Dyadic International's long position.| Pasithea Therapeutics vs. Cue Biopharma | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Inhibrx | Pasithea Therapeutics vs. Molecular Partners AG |
| Dyadic International vs. Cue Biopharma | Dyadic International vs. Eliem Therapeutics | Dyadic International vs. Inhibrx | Dyadic International vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |